Generex Biotechnology Corp (GNBT) SEC Filing 10-K Annual report for the fiscal year ending Tuesday, July 31, 2018

10-K Annual Report Summary
10-K Annual Report
10-K YoY Changes
Generex Biotechnology Corp
Ticker: GNBT CIK: 1059784

Document and Entity Information - USD ($)	12 Months Ended
Document and Entity Information - USD ($)	Jul. 31, 2018	Oct. 26, 2018
Document And Entity Information
Entity Registrant Name	GENEREX BIOTECHNOLOGY CORP
Entity Central Index Key	0001059784
Current Fiscal Year End Date	--07-31
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	false
Trading Symbol	GNBT
Document Type	10-K
Amendment Flag	false
Document Period End Date	Jul. 31, 2018
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2018
Entity Well-Known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Common Stock, Shares Outstanding		1,065,093
Entity Public Float	$ 2,200,000

View differences made from one year to another to evaluate Generex Biotechnology Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ) — *Sample 10-K Year-over-Year (YoY) Comparison*

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were ~~removed~~ , added and changed by Generex Biotechnology Corp.

Continue

Please wait while we load the requested 10-K report or click the link below:

https://last10k.com/sec-filings/report/1059784/000160706218000361/gnbt073018form10k.htm